Geron (GERN) announces the enrollment of the first patient in a second randomized Phase 2...

|About: Geron Corporation (GERN)|By:, SA News Editor

Geron (GERN) announces the enrollment of the first patient in a second randomized Phase 2 clinical trial of its imetelstat drug, in combination with paclitaxel, for patients with breast cancer. Shares +0.7%. (PR)